Tandem Diabetes Care, Inc. (TNDM) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Tandem Diabetes Care Second Quarter 2025 earnings conference call. At this time, all participants are in a listen only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message, advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Susan Morrison, Executive Vice President and Chief Administrative Officer. Please go ahead. Hello everyone and welcome to Tandem Second Quarter 2025 earnings call. Today's discussion will include forward looking statements. These statements reflect management's expectations about future events, our product pipeline, development timelines and financial performance and operating plans and speak only as of today's date. There are risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward looking statements, which are described in our press release issued earlier today and under the risk factors portion of our most recent quarterly report on form 10Q. Today's discussion will also include references to a number of gap and non-gap financial measures. Please refer to our earnings release issued earlier today and available on the Investor Center portion of our website for a reconciliation of these measures to their most directly comparable gap financial measure and other information regarding our use of non-gap financial measures. Today's call will be led by John Sheridan, Tandem's President and CEO, who will be jo...